# Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

> **NCT02004067** · PHASE4 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 100 (actual)

## Conditions studied

- Primary Sjogren Syndrome
- Secondary Sjogren Syndrome
- Aqueous Deficient Dry Eye Disease
- Evaporative Dry Eye Disease

## Interventions

- **DRUG:** Restasis
- **DRUG:** Refresh Endura

## Key facts

- **NCT ID:** NCT02004067
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004067, "Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02004067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*